BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.
BenchSci has raised $69.6M in total funding. The most recent round was Series D. The last funding was announced in May 2023.
BenchSci's investors include Inovia Capital, TCV, Radical Ventures, Northleaf Capital Partners, Generation Investment Management.
BenchSci is headquartered in Toronto, Canada.
BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.
BenchSci is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BenchSci — Funding & Investors." VCBacked, May 25, 2023, https://www.vcbacked.co/company/benchsci. Accessed September 30, 2026.
VCBacked. (2023). BenchSci — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/benchsci
{{cite web |title=BenchSci — Funding & Investors |url=https://www.vcbacked.co/company/benchsci |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated